Eris Lifesciences Gets Brazil Health Nod

By By Rediff Money Desk, New Delhi
Aug 25, 2025 14:04
Eris Lifesciences unit in Ahmedabad receives approval from Brazil's ANVISA, enabling entry into the largest South American pharma market.
New Delhi, Aug 25 (PTI) Eris Lifesciences on Monday said one of its manufacturing units in Ahmedabad has received approval from Brazil's national health regulatory agency ANVISA.

The approval follows a successful inspection conducted by the agency in May 2025, and enables the drugmaker to enter Brazil, the largest pharmaceutical market in South America, Eris Lifesciences said in a statement.

Shares of the company were trading 0.2 per cent up at Rs 1,772.50 apiece on BSE.
Source: PTI
Read More On:
eris lifesciencesanvisabrazilpharmaceutical markethealth regulator
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Unilever: India Growth & GST Impact

Unilever sees huge opportunities in India due to high GDP growth and GST cuts. HUL...

Trai Recommends 6 GHz, E, V Band Allocation

Trai suggests administrative allocation of 6 GHz, E, and V bands for telecom backhaul....

TotalEnergies Sells Stake in Adani Green Energy

TotalEnergies sells 1.74% stake in Adani Green Energy for Rs 2,778 cr. Stake reduced to...

TCS Acquires Coastal Cloud for $700 Million

TCS acquires Coastal Cloud for USD 700 million, strengthening its Salesforce and AI...

JSW Paints Acquires AkzoNobel India Stake

JSW Paints completes acquisition of majority stake in AkzoNobel India, becoming the...

Park Medi World IPO Subscribed 52% on Day 1

Park Medi World''s IPO received 52% subscription on day 1. The Rs 920-crore IPO closes...

Dasnac Invests Rs 2,000 Cr in Noida Luxury Housing

Dasnac to invest Rs 2,000 crore in a luxury housing project, Dasnac Westminster, in...

Nephrocare IPO Subscribed 12% on Day 1

Nephrocare Health Services IPO received 12% subscription on day 1. IPO details, price...

Wakefit IPO Subscribed Over 2 Times

Wakefit''s Rs 1,289-cr IPO was subscribed over 2 times on the final day. Details on...

IAN Group to Deploy USD 100M Alpha Fund by 2027

IAN Group to deploy its USD 100 million IAN Alpha Fund in early-stage startups by 2027....

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com